Friedman, Senate push transparency in pharmaceutical drug costs

Massachusetts has taken lots of steps to rein in runaway spending on healthcare, but one area has largely avoided state regulation: prescription drugs. “If we’re really going to have a complete picture of what affects health care costs and we are committed, which we are, to our cost growth benchmarks, we have to look at(...)

Read More »